North Texas Clinical Trials | Fort Worth, TX

Research site

(Unclaimed)

Location

1650 W Rosedale, Suite 300, Fort Worth, Texas, United States of America

Site insights

Top conditions

Top treatments

Rapastinel

Seltorexant

Ecopipam

Aticaprant

Iclepertin

Troriluzole

Psilocybin

Ropanicant

BRII-296

CYB003

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 28 total trials

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011)

This is a randomized, double-blind, sham-controlled, adaptive-design pivotal study of sensory stimulation in subjects with mild to moderate Alzheimer...

Active, not recruiting

Alzheimer Disease 6

Cognitive Impairment

Device: Sensory Stimulation System (GS120) - Sham

Device: Sensory Stimulation System (GS120) - Active

Locations recently updated

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder (EMBRACE)

The purpose of this study is to determine the efficacy, safety and tolerability of CYB003 compared to matching placebo as adjunctive treatment in pat...

Enrolling

Depression in Adults

Depression Disorders

Drug: CYB003

Behavioral: Psychological Support

Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

Efficacy, Safety, and Tolerability of two administrations of COMP360 in participants with treatment-resistant depression (TRD)

Active, not recruiting

Treatment Resistant Depression

Drug: Psilocybin

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

This is an open-label extension for a multicenter, randomized, double-blind, sham-controlled, adaptive design pivotal study.Participants who complete...

Invitation-only

Alzheimer Disease

Device: Sensory Stimulation System (GS120) - Active

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

The purpose of this study is to know how well seltorexant works, and also to evaluate safety and maintenance effect of seltorexant compared with plac...

Enrolling

Depressive Disorder, Major

Drug: Selective Serotonin Reuptake Inhibitor (SSRI)/Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)

Drug: Placebo